Synergistic Therapeutics Announces It Has Obtained a US Patent for Its Topical Analgesic Lotion, Dolore

News provided by

Nov 19, 2019, 07:00 ET

NAPLES, Fla., Nov. 19, 2019 /PRNewswire/ -- Synergistic Therapeutics LLC has recently announced the issuance of a U.S. Patent for a Topical Analgesic Lotion that relieves pain. Synergistic Therapeutics LLC, a Florida-based company formed in 2015, specializes in manufacturing and formulating topical and sublingual pharmaceutical solutions.

Dolore is a topical pharmaceutical composition with unique properties and multiple components, including the addition of a perfusing agent, all combining to eliminate a wide variety of pain complications. Using a topical medication over an oral consumption is especially beneficial for those who use pain medications on a regular basis¹.

It provides deep penetration to get to the root of the problem area and remains focused on the affected location while limiting systemic side effects². With its patented prescription formula, Dolore has shown dramatic positive efficacy and scientific study results³.

In addition to the analgesic lotion, Synergistic Therapeutics maintains and holds patents for other products, including Felicita, Cresere, and Minervo. Felicita is a sublingual ketamine lozenge to treat depression, including treatment-resistant depression (TRD).
Cresere is a topical hair loss slowing and regrowth lotion. Minervo is a therapeutic neuropathic pain lotion. The company also is developing a female sexual dysfunction treatment.

Contact the company via email at [email protected] for more information and inquiries.

Source (1). https://pediatrics.aappublications.org/content/100/1/143

Source (2). https://www.ncbi.nlm.nih.gov/pubmed/29562618

Source (3). Internal non-published studies

Related Images

image1.jpg

SOURCE Synergistic Therapeutics